Item 7.01. Regulation FD.
The Company has updated its Corporate Presentation that will be available on the Investor Relations page of the Company's website at https://acertx.com/investor-relations and will be used at investor and other meetings. A copy of the updated Corporate Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Company does not undertake to update this presentation.
The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 8.01. Other Events.
Sales Pursuant to At-the-Market Offering Program
During the period of
The shares sold under the Sales Agreement were issued and sold pursuant to a
shelf registration statement on Form S-3 (File No. 333-228319) previously filed
by the Company and declared effective by the
Sales Pursuant to Purchase Agreement with
During the period of
The shares issued to Lincoln Park under the Purchase Agreement were registered
for resale pursuant to a registration statement on Form S-1 (File No.
333-238192) previously filed by the Company and declared effective by the
As of
Projected Cash Runway
After completion of the matters described above, combined with its existing
resources, the Company believes that it has sufficient cash and cash equivalents
on hand to fund its currently anticipated operating and capital requirements for
its development programs into the second quarter of 2021. This statement is
based on management's current expectations and involves risks and uncertainties.
Actual results and performance could differ materially from that estimate.
Disclosure regarding those risks and uncertainties is included in the Company's
This Current Report on Form 8-K does not constitute an offer to sell nor the solicitation of an offer to buy shares of the Company's common stock, nor shall there be any sale of shares of the Company's common stock in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
2 --------------------------------------------------------------------------------
Item 9.01.Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1Acer Therapeutics Inc. Corporate Presentation,January 15, 2021 . 3
--------------------------------------------------------------------------------
© Edgar Online, source